Q01063
Gene name |
Pde4d |
Protein name |
3',5'-cyclic-AMP phosphodiesterase 4D |
Names |
EC 3.1.4.53 , DPDE3 , cAMP-specific phosphodiesterase 4D |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:238871 |
EC number |
3.1.4.53: Phosphoric diester hydrolases |
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
325-654 (3'5'-cyclic nucleotide phosphodiesterase, catalytic domain) |
Relief mechanism |
PTM |
Assay |
|
Target domain |
325-654 (3'5'-cyclic nucleotide phosphodiesterase, catalytic domain) |
Relief mechanism |
PTM |
Assay |
|
Accessory elements
No accessory elements
References
- Yeon JH et al. (2016) "Systems-wide Identification of cis-Regulatory Elements in Proteins", Cell systems, 2, 89-100
- Burgin AB et al. (2010) "Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety", Nature biotechnology, 28, 63-70
- Beard MB et al. (2000) "UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase family form a discrete module via electrostatic interactions", The Journal of biological chemistry, 275, 10349-58
- Houslay MD et al. (2010) "Putting the lid on phosphodiesterase 4", Nature biotechnology, 28, 38-40
Autoinhibited structure

Activated structure

1 structures for Q01063
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-Q01063-F1 | Predicted | AlphaFoldDB |
40 variants for Q01063
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs3389286275 | 20 | L>M | No | EVA | |
rs3404633012 | 58 | Q>H | No | EVA | |
rs3389269076 | 67 | N>I | No | EVA | |
rs3404938152 | 112 | G>E | No | EVA | |
rs3404205951 | 113 | S>P | No | EVA | |
rs3389309752 | 116 | I>N | No | EVA | |
rs3389318706 | 121 | F>C | No | EVA | |
rs3389318728 | 165 | F>Y | No | EVA | |
rs3389276554 | 174 | T>I | No | EVA | |
rs3412107645 | 216 | A>S | No | EVA | |
rs3404939377 | 262 | S>R | No | EVA | |
rs3404939390 | 263 | R>G | No | EVA | |
rs3404939381 | 263 | R>Q | No | EVA | |
rs3389303280 | 325 | V>A | No | EVA | |
rs3389300693 | 367 | F>I | No | EVA | |
rs3389286225 | 380 | V>E | No | EVA | |
rs3389260294 | 393 | H>Q | No | EVA | |
rs3404940754 | 499 | Q>* | No | EVA | |
rs3389304974 | 503 | K>R | No | EVA | |
rs3389309737 | 511 | A>T | No | EVA | |
rs3404640214 | 513 | D>A | No | EVA | |
rs3403878407 | 514 | M>R | No | EVA | |
rs3404416764 | 546 | D>V | No | EVA | |
rs3389299928 | 564 | T>P | No | EVA | |
rs3389260236 | 611 | V>M | No | EVA | |
rs3389297877 | 636 | I>T | No | EVA | |
rs3389300742 | 646 | W>L | No | EVA | |
rs3389295860 | 652 | P>T | No | EVA | |
rs3389260251 | 680 | E>D | No | EVA | |
rs3389304984 | 683 | C>Y | No | EVA | |
rs3389299971 | 695 | V>L | No | EVA | |
rs3389299971 | 695 | V>M | No | EVA | |
rs3389314293 | 705 | K>M | No | EVA | |
rs3403191024 | 712 | S>L | No | EVA | |
rs3389295900 | 718 | P>L | No | EVA | |
rs3389297811 | 731 | E>D | No | EVA | |
rs260629578 | 735 | P>S | No | EVA | |
rs3389299951 | 739 | V>A | No | EVA | |
rs3389305150 | 743 | C>Y | No | EVA | |
rs3389305230 | 745 | P>S | No | EVA |
No associated diseases with Q01063
15 regional properties for Q01063
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Protein kinase domain | 590 - 938 | IPR000719 |
domain | Serine-threonine/tyrosine-protein kinase, catalytic domain | 591 - 923 | IPR001245 |
conserved_site | Tyrosine-protein kinase, receptor class III, conserved site | 649 - 662 | IPR001824 |
domain | Immunoglobulin subtype 2 | 49 - 104 | IPR003598-1 |
domain | Immunoglobulin subtype 2 | 224 - 298 | IPR003598-2 |
domain | Immunoglobulin subtype | 43 - 112 | IPR003599-1 |
domain | Immunoglobulin subtype | 121 - 205 | IPR003599-2 |
domain | Immunoglobulin subtype | 218 - 309 | IPR003599-3 |
domain | Immunoglobulin subtype | 321 - 411 | IPR003599-4 |
domain | Immunoglobulin-like domain | 212 - 309 | IPR007110-1 |
domain | Immunoglobulin-like domain | 427 - 508 | IPR007110-2 |
active_site | Tyrosine-protein kinase, active site | 789 - 801 | IPR008266 |
domain | Immunoglobulin-like beta-sandwich domain | 220 - 303 | IPR013151 |
binding_site | Protein kinase, ATP binding site | 596 - 624 | IPR017441 |
domain | Tyrosine-protein kinase, catalytic domain | 590 - 925 | IPR020635 |
Functions
Description | ||
---|---|---|
EC Number | 3.1.4.53 | Phosphoric diester hydrolases |
Subcellular Localization |
|
|
PANTHER Family | ||
PANTHER Subfamily | ||
PANTHER Protein Class | ||
PANTHER Pathway Category | No pathway information available |
10 GO annotations of cellular component
Name | Definition |
---|---|
apical plasma membrane | The region of the plasma membrane located at the apical end of the cell. |
calcium channel complex | An ion channel complex through which calcium ions pass. |
centrosome | A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle. |
cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
myofibril | The contractile element of skeletal and cardiac muscle; a long, highly organized bundle of actin, myosin, and other proteins that contracts by a sliding filament mechanism. |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
perinuclear region of cytoplasm | Cytoplasm situated near, or occurring around, the nucleus. |
potassium channel complex | An ion channel complex through which potassium ions pass. |
protein-containing complex | A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together. |
voltage-gated calcium channel complex | A protein complex that forms a transmembrane channel through which calcium ions may pass in response to changes in membrane potential. |
11 GO annotations of molecular function
Name | Definition |
---|---|
3',5'-cyclic-AMP phosphodiesterase activity | Catalysis of the reaction |
3',5'-cyclic-GMP phosphodiesterase activity | Catalysis of the reaction |
3',5'-cyclic-nucleotide phosphodiesterase activity | Catalysis of the reaction |
ATPase binding | Binding to an ATPase, any enzyme that catalyzes the hydrolysis of ATP. |
beta-2 adrenergic receptor binding | Binding to a beta-2 adrenergic receptor. |
calcium channel regulator activity | Modulates the activity of a calcium channel. |
cyclic-nucleotide phosphodiesterase activity | Catalysis of the reaction |
enzyme binding | Binding to an enzyme, a protein with catalytic activity. |
metal ion binding | Binding to a metal ion. |
signaling receptor regulator activity | Binds to and modulates the activity of a receptor. |
transmembrane transporter binding | Binding to a transmembrane transporter, a protein or protein complex that enables the transfer of a substance, usually a specific substance or a group of related substances, from one side of a membrane to the other. |
31 GO annotations of biological process
Name | Definition |
---|---|
adrenergic receptor signaling pathway | A G protein-coupled receptor signaling pathway initiated by a ligand binding to an adrenergic receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process. |
cAMP catabolic process | The chemical reactions and pathways resulting in the breakdown of the nucleotide cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate). |
cAMP-mediated signaling | Any intracellular signal transduction in which the signal is passed on within the cell via cyclic AMP (cAMP). Includes production of cAMP, and downstream effectors that further transmit the signal within the cell. |
cellular response to cAMP | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus. |
cellular response to epinephrine stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epinephrine stimulus. Epinephrine is a catecholamine that has the formula C9H13NO3; it is secreted by the adrenal medulla to act as a hormone, and released by certain neurons to act as a neurotransmitter active in the central nervous system. |
cellular response to follicle-stimulating hormone stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a follicle-stimulating hormone stimulus. |
cellular response to lipopolysaccharide | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
establishment of endothelial barrier | The establishment of a barrier between endothelial cell layers, such as those in the brain, lung or intestine, to exert specific and selective control over the passage of water and solutes, thus allowing formation and maintenance of compartments that differ in fluid and solute composition. |
memory | The activities involved in the mental information processing system that receives (registers), modifies, stores, and retrieves informational stimuli. The main stages involved in the formation and retrieval of memory are encoding (processing of received information by acquisition), storage (building a permanent record of received information as a result of consolidation) and retrieval (calling back the stored information and use it in a suitable way to execute a given task). |
multicellular organism growth | The increase in size or mass of an entire multicellular organism, as opposed to cell growth. |
negative regulation of cAMP-mediated signaling | Any process which stops, prevents, or reduces the frequency, rate or extent of cAMP-mediated signaling. |
negative regulation of heart contraction | Any process that stops, prevents, or reduces the frequency, rate or extent of heart contraction. |
negative regulation of peptidyl-serine phosphorylation | Any process that stops, prevents, or reduces the frequency, rate or extent of the phosphorylation of peptidyl-serine. |
negative regulation of relaxation of cardiac muscle | Any process that stops, prevents or reduces the frequency, rate or extent of relaxation of cardiac muscle. |
neutrophil chemotaxis | The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding. |
neutrophil migration | The movement of a neutrophil within or between different tissues and organs of the body. |
ovulation from ovarian follicle | The process leading to the rupture of the follicle, releasing the centrally located oocyte into the oviduct. An example of this is found in Mus musculus. |
positive regulation of cell-cell adhesion | Any process that activates or increases the rate or extent of cell adhesion to another cell. |
positive regulation of heart rate | Any process that activates or increases the frequency or rate of heart contraction. |
positive regulation of protein phosphorylation | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
positive regulation of smooth muscle cell migration | Any process that activates, maintains or increases the frequency, rate or extent of smooth muscle cell migration. |
positive regulation of smooth muscle cell proliferation | Any process that activates or increases the rate or extent of smooth muscle cell proliferation. |
protein-containing complex assembly | The aggregation, arrangement and bonding together of a set of macromolecules to form a protein-containing complex. |
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | Any process that modulates the frequency, rate or extent of generation of calcium ion transmembrane transport via high voltage-gated calcium channel. |
regulation of cAMP-mediated signaling | Any process which modulates the frequency, rate or extent of cAMP-mediated signaling. |
regulation of cardiac muscle cell contraction | Any process that modulates the frequency, rate or extent of cardiac muscle cell contraction. |
regulation of cell communication by electrical coupling involved in cardiac conduction | Any process that modulates the frequency, rate or extent of cell communication by electrical coupling involved in cardiac conduction. |
regulation of G protein-coupled receptor signaling pathway | Any process that modulates the frequency, rate or extent of G protein-coupled receptor signaling pathway. |
regulation of heart rate | Any process that modulates the frequency or rate of heart contraction. |
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | Any process that modulates the rate, frequency or extent of release of sequestered calcium ion into cytosol by the sarcoplasmic reticulum, the process in which the release of sequestered calcium ion by sarcoplasmic reticulum into cytosol occurs via calcium release channels. |
smooth muscle contraction | A process in which force is generated within smooth muscle tissue, resulting in a change in muscle geometry. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. Smooth muscle differs from striated muscle in the much higher actin/myosin ratio, the absence of conspicuous sarcomeres and the ability to contract to a much smaller fraction of its resting length. |
32 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q28156 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | Bos taurus (Bovine) | SS |
P23439 | PDE6B | Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | Bos taurus (Bovine) | PR |
P52731 | PDE6C | Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | Gallus gallus (Chicken) | PR |
H2QL32 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | Pan troglodytes (Chimpanzee) | PR |
Q9VJ79 | Pde11 | Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 | Drosophila melanogaster (Fruit fly) | SS |
Q9W4T4 | dnc | 3',5'-cyclic-AMP phosphodiesterase, isoform I | Drosophila melanogaster (Fruit fly) | SS |
Q9HCR9 | PDE11A | Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | Homo sapiens (Human) | SS |
O76083 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | Homo sapiens (Human) | PR |
Q07343 | PDE4B | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (Human) | EV SS |
O76074 | PDE5A | cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (Human) | EV |
Q08493 | PDE4C | cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Homo sapiens (Human) | EV SS |
P51160 | PDE6C | Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | Homo sapiens (Human) | PR |
P27815 | PDE4A | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (Human) | EV SS |
P35913 | PDE6B | Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | Homo sapiens (Human) | PR |
Q9Y233 | PDE10A | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Homo sapiens (Human) | PR |
Q08499 | PDE4D | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (Human) | EV |
O89084 | Pde4a | 3',5'-cyclic-AMP phosphodiesterase 4A | Mus musculus (Mouse) | SS |
Q3UEI1 | Pde4c | cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Mus musculus (Mouse) | PR |
O70628 | Pde9a | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | Mus musculus (Mouse) | PR |
Q8CA95 | Pde10a | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Mus musculus (Mouse) | PR |
P0C1Q2 | Pde11a | Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | Mus musculus (Mouse) | SS |
P23440 | Pde6b | Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | Mus musculus (Mouse) | PR |
Q8CG03 | Pde5a | cGMP-specific 3',5'-cyclic phosphodiesterase | Mus musculus (Mouse) | SS |
Q8QZV1 | Pde9a | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | Rattus norvegicus (Rat) | PR |
P14646 | Pde4b | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Rattus norvegicus (Rat) | SS |
Q8VID6 | Pde11a | Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | Rattus norvegicus (Rat) | SS |
O54735 | Pde5a | cGMP-specific 3',5'-cyclic phosphodiesterase | Rattus norvegicus (Rat) | SS |
P14644 | Pde4c | cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Rattus norvegicus (Rat) | PR |
P54748 | Pde4a | 3',5'-cyclic-AMP phosphodiesterase 4A | Rattus norvegicus (Rat) | SS |
Q9QYJ6 | Pde10a | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Rattus norvegicus (Rat) | PR |
P14270 | Pde4d | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Rattus norvegicus (Rat) | PR |
Q22000 | pde-4 | Probable 3',5'-cyclic phosphodiesterase pde-4 | Caenorhabditis elegans | PR |
10 | 20 | 30 | 40 | 50 | 60 |
MERDTCDVLS | RSKSASEETL | HSCNEEEDPF | RGMEPYLVRR | LSSRSIQLPP | LAFRQLEQAD |
70 | 80 | 90 | 100 | 110 | 120 |
LRSESENIPR | PTSLPLKILP | LIAVTSADSS | GFDVDNGTSA | GRSPLDPMTS | PGSGLILQAN |
130 | 140 | 150 | 160 | 170 | 180 |
FVHSQRRESF | LYRSDSDYDL | SPKSMSRNSS | IASDIHGDDL | IVTPFAQVLA | SLRTVRNNFA |
190 | 200 | 210 | 220 | 230 | 240 |
ALTNLQDRAP | SKRSPMCNQP | SINKATITEE | AYQKLASETL | EELDWCLDQL | ETLQTRHSVS |
250 | 260 | 270 | 280 | 290 | 300 |
EMASNKFKRM | LNRELTHLSE | MSRSGNQVSE | YISNTFLDKQ | HEVEIPSPTQ | KEKEKKKRPM |
310 | 320 | 330 | 340 | 350 | 360 |
SQISGVKKLM | HSSSLTNSCI | PRFGVKTEQE | DVLAKELEDV | NKWGLHVFRI | AELSGNRPLT |
370 | 380 | 390 | 400 | 410 | 420 |
VIMHTIFQER | DLLKTFKIPV | DTLITYLMTL | EDHYHADVAY | HNNIHAADVV | QSTHVLLSTP |
430 | 440 | 450 | 460 | 470 | 480 |
ALEAVFTDLE | ILAAIFASAI | HDVDHPGVSN | QFLINTNSEL | ALMYNDSSVL | ENHHLAVGFK |
490 | 500 | 510 | 520 | 530 | 540 |
LLQEENCDIF | QNLTKKQRQS | LRKMVIDIVL | ATDMSKHMNL | LADLKTMVET | KKVTSSGVLL |
550 | 560 | 570 | 580 | 590 | 600 |
LDNYSDRIQV | LQNMVHCADL | SNPTKPLQLY | RQWTDRIMEE | FFRQGDRERE | RGMEISPMCD |
610 | 620 | 630 | 640 | 650 | 660 |
KHNASVEKSQ | VGFIDYIVHP | LWETWADLVH | PDAQDILDTL | EDNREWYQST | IPQSPSPAPD |
670 | 680 | 690 | 700 | 710 | 720 |
DQEEGRQGQT | EKFQFELTLE | EDCESDTEKD | SGSQVEEDTS | CSDSKTLCTQ | DSESTEIPLD |
730 | 740 | ||||
EQVEEEAVAE | EESQPETCVP | DDCCPDT |